Earnings Call · Q2 FY2021·2021-08-06

Q2 21EPS +9.84%·Rev n/aQ1 21EPS +46.48%·Rev n/aQ4 20EPS -14.89%·Rev n/aQ3 20EPS +10.23%·Rev n/a⚠ consensus missing

ANI PHARMACEUTICALS INC ANIP

Lisa Wilson — Investor Relations

Nikhil Lalwani — President and Chief Executive Officer

Steve Carey — Chief Financial Officer

−0.8%1d on move date−1.0% vs SPY3d−8.4%5d−9.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ANIP calls or request research access.

More ANIP calls Browse calls Request research access